Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

    Kidney International Date published:

  • POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION

    Kidney International Reports Date published:

  • POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)

    Kidney International Reports Date published:

  • Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis

    Clinical Kidney Journal Date published:

  • Can Peer Review Be Kinder? Supportive Peer Review: A Re-Commitment to Kindness and a Call to Action

    Canadian Journal of Kidney Health and Disease Date published:

  • Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study

    Canadian Journal of Kidney Health and Disease Date published:

  • Alternative Clinical Trial Designs for Nephrology Research

    Innovations in Nephrology Date published:

  • Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review

    Clinical Kidney Journal Date published:

  • Digital health and artificial intelligence in kidney research: a report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting

    Nephrology Dialysis Transplantation Date published:

  • The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

    American Journal of Nephrology Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    European Heart Journal Date published:

  • Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure

    Clinical Journal of the American Society of Nephrology Date published:

  • Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

    Trials Date published:

  • Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program

    Diabetologia Date published:

  • Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

    European Heart Journal Date published:

  • Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis

    Diabetes, Obesity and Metabolism Date published: